You have 9 free searches left this month | to do more
Showing 1 - 25 of
800 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
  • Multiple Myeloma
  • Palo Alto, California
  • +10 more
2021-11-12
Nov 12, 2021
S
Unknown status
  • Multiple Myeloma
  • CAR T cells
  • Shenzhen, Guangdong, China
  • +1 more
2019-09-18
Sep 18, 2019
Z
Terminated
  • Relapsed/Refractory Multiple Myeloma(MM)
  • CART therapy in Relapsed/Refractory multiple myeloma
  • Guangdong, Guangdong, China
    Southern Medical University Zhujiang Hospital
2021-09-17
Sep 17, 2021
F
Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-06-08
Jun 8, 2021
T
Unknown status
  • Relapsed and Refractory Multiple Myeloma
  • BCMA CAR-T Cells
  • Shenzhen, Guangdong, China
    Pregene Shenzhen Biotechnology Co., Ltd.
2018-09-06
Sep 6, 2018
F
Suspended
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • BCMA-specific CAR-expressing T Lymphocytes
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-07-30
Jul 30, 2021
H
Recruiting
  • Multiple Myeloma
  • Human BCMA targeted T Cells Injection
  • Zhengzhou, Henan, China
  • +2 more
2021-02-25
Feb 25, 2021
K
Active, not recruiting
  • B Cell Lymphoma
  • +5 more
  • CAR-CD19 T cell
  • +5 more
  • Wenzhou, Zhejiang, China
    First Affiliated Hospital of Wenzhou Medical University
2020-10-05
Oct 5, 2020
P
Completed
  • Multiple Myeloma
  • T cell infusion agent targeting BCMA chimeric antigen receptor
  • Hangzhou, Zhejiang, China
    No.3, Qingchun East Road
2020-11-25
Nov 25, 2020
U
Not yet recruiting
  • Multiple Myeloma
  • BCMA CAR T cells
  • BCMA/CD19 CAR T cells
  • (no location specified)
2021-10-05
Oct 5, 2021
P
Enrolling by invitation
  • Multiple Myeloma
  • Rimiducid may be administered as indicated
  • Gilbert, Arizona
  • +15 more
2021-08-09
Aug 9, 2021
S
Not yet recruiting
  • Multiple Myeloma
  • CXCR4 modified anti-BCMA CAR T cells
  • (no location specified)
2021-04-07
Apr 7, 2021
X
Active, not recruiting
  • Refractory or Relapsed Multiple Myeloma
  • CAR-BCMA T cells
  • +2 more
  • Shanghai, Shanghai, China
    Xin Hua Hospital of Shanghai Jiao Tong University of Medicine
2020-10-08
Oct 8, 2020
F
Active, not recruiting
  • Refractory or Relapsed Multiple Myeloma
  • CAR-BCMA T cells
  • +2 more
  • Hangzhou, Zhejiang, China
    First Affiliated Hospital of Zhejiang University
2020-10-06
Oct 6, 2020
Z
Recruiting
  • Scleroderma
  • Autoimmune Diseases
  • Assigned Interventions CD19/BCMA CAR T-cells
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
2021-10-11
Oct 11, 2021
Z
Recruiting
  • Immune Nephritis
  • +2 more
  • Assigned Interventions CD19/BCMA CAR T-cells
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
2021-10-11
Oct 11, 2021
Z
Recruiting
  • Sjogren's Syndrome
  • Autoimmune Diseases
  • Assigned Interventions CD19/BCMA CAR T-cells
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
2021-10-11
Oct 11, 2021
Z
Recruiting
  • Systemic Lupus Erythematosus
  • Autoimmune Diseases
  • Assigned Interventions CD19/BCMA CAR T-cells
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital,College of Medicine, Zhejiang Univ
2021-08-31
Aug 31, 2021
X
Not yet recruiting
  • Multiple Myeloma, Refractory
  • Anti-BCMA CAR-NK Cells
  • +2 more
  • Chongqing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
2021-08-14
Aug 14, 2021
U
Completed
  • Multiple Myeloma
  • CART-BCMA
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2020-08-03
Aug 3, 2020
B
Suspended
  • Multiple Myeloma
  • BCMA-CART
  • Shanghai, Shanghai, China
    Shanghai Bioray Laboratories INC.
2021-09-23
Sep 23, 2021
H
Recruiting
  • Dose Escalation and Safety
  • CART BCMA
  • Jerusalem, Israel
    Hadassah University Hospital
2021-01-21
Jan 21, 2021
B
Recruiting
  • Multiple Myeloma
  • BCMA-UCART
  • Shanghai, Shanghai, China
    Shanghai Tongji Hospital
2021-03-07
Mar 7, 2021
X
Recruiting
  • Multiple Myeloma
  • anti-BCMA CAR-T
  • ChongQing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
2020-11-14
Nov 14, 2020